EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis

Rohit Upadhyay, Alexia Orellana, George C Tsokos iD, Rhea Bhargava iD

Arthritis & Rheumatology · 07.07.2026

DOI: 10.1002/art.70260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 07.07.2026. Verfasst von Rohit Upadhyay und 3 weiteren Autor:innen. Beteiligte Einrichtung: John W. Deming Department of Medicine, Section of Nephrology & Hypertension, Tulane University School of Medicine, New Orleans, Louisiana. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) that can lead to end‐stage kidney disease and increased mortality. IgG from patients with LN displays abnormal glycosylation, contributing to podocyte injury. CLEC7A (C‐type lectin domain family 7 member A) is a transmembrane lectin receptor that recognizes fucose on IgG. This study investigates the role of lectin‐glycan interactions in LN‐related podocyte dysfunction.

Methods

IgG isolated from patients with active LN and healthy controls was exposed to differentiated human podocytes. Gene and protein responses were assessed by quantitative polymerase chain reaction, Western blotting, immunofluorescence, phalloidin staining, calcium flux, and wound‐healing assays. Human kidney biopsies and MRL/lpr mouse kidneys were examined to validate CLEC7A–spleen tyrosine kinase (SYK) pathway activation and the glycan‐dependent effects of LN‐IgG.

Results

Human podocytes exposed to the CLEC7A ligand curdlan or LN‐IgG, but not healthy control IgG or IgG from patients with SLE without nephritis, showed increased CLEC7A expression, impaired motility, cytoskeleton disruption, and reduced nephrin expression. Deglycosylation of LN‐IgG blocked CLEC7A binding and preserved podocyte function. Mechanistically, curdlan and LN‐IgG increased calcium flux and activated SYK. MRL/ lpr mice with nephritis exhibited elevated podocyte CLEC7A and SYK expression. Similarly, podocytes in kidney biopsies from patients with active LN exhibit increased expression of SYK and CLEC7A compared with healthy controls. Pharmacological SYK inhibition or CLEC7A silencing prevented podocyte injury.

Conclusion

We reveal a novel IgG lectin‐glycan‐CLEC7A‐SYK axis involved in the pathogenesis of LN, which can be targeted therapeutically in patients with LN. image

Autor:innen und Institutionen

  • John W. Deming Department of Medicine, Section of Nephrology & Hypertension, Tulane University School of Medicine, New Orleans, Louisiana.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: George C Tsokos, Rhea Bhargava

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • U.S. Department of Defense
  • Dialysis Clinics
  • National Institute of General Medical Sciences

Zitieren

APA

Upadhyay, R., Orellana, A., Tsokos, G. C., & Bhargava, R. (2026). IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.70260

Vancouver

Upadhyay R, Orellana A, Tsokos GC, Bhargava R. IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis. Arthritis & Rheumatology. 2026. doi:10.1002/art.70260

BibTeX
@article{Upadhyay2026,
  author = {Upadhyay, Rohit and Orellana, Alexia and Tsokos, George C and Bhargava, Rhea},
  title = {IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70260}
}
Kostenlos starten →